Interleukin-1β Exacerbates the Catabolic Effects of Human Nucleus Pulposus Cells Through Activation of the Nuclear Factor Kappa B Signaling Pathway Under Hypoxic Conditions
Overview
Pharmacology
Toxicology
Affiliations
Objective: To determine the regulatory role of interleukin 1 beta (IL-1β) in the Nuclear Factor kappa B (NF-κB) -mediated catabolic effects of the nucleus pulposus cells in human intervertebral disc degeneration under hypoxic conditions.
Patients And Methods: Human nucleus pulposus cells were cultured and exposed to IL-1β under hypoxic or normoxic environments, with or without NF-κB inhibition. The cell growth was determined using cell counting kit-8; gene and protein expressions were analyzed by Real-time polymerase chain reaction and Western blotting, respectively.
Results: Co-treatment with IL-1β and hypoxia decreased cell viability in human nucleus pulposus cells. There was a positive effect of IL-1β on human nucleus pulposus cells under hypoxia, which was through the up-regulation of matrix metalloproteinase-3 (MMP-3), MMP-13, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-4, and ADAMTS-5. IL-1β-induced expressions of MMP-3, MMP-9, ADAMTS-4, and ADAMTS-5 under hypoxia were accompanied by increased activation of NF-κB. Inhibition of NF-κBp65 by small interfering RNA or specific inhibitor BAY11-7082 blocked IL-1β-dependent gene upregulation of MMP-3, MMP-13, ADAMTS-4, and ADAMTS-5 in a hypoxic environment. The gene expression of aggrecan was decreased by IL-1β under hypoxic conditions, which was reversed by either BAY11-7082 or NF-κBp65 knockdown.
Conclusions: IL-1β and hypoxia synergetically contributed to the catabolic effects of the nucleus pulposus cells by upregulating the expression of MMP-3, MMP-13, ADAMTS-4 and ADAMTS-5 through the activation of NF-κB signaling pathway, indicating that the NF-κB signaling pathway is a key mediator of intervertebral disc degeneration.
Yu L, Hao Y, Ren Z, Zhu G, Zhou W, Lian X In Vitro Cell Dev Biol Anim. 2024; 60(3):287-299.
PMID: 38485818 PMC: 11014818. DOI: 10.1007/s11626-024-00883-6.
Peredo A, Gullbrand S, Friday C, Orozco B, Dehghani B, Jenk A Sci Transl Med. 2023; 15(722):eadf1690.
PMID: 37967202 PMC: 10812087. DOI: 10.1126/scitranslmed.adf1690.
Altuntas C, Alper M, Keles Y, Sav F, Kockar F Mol Cell Biochem. 2022; 478(5):1151-1160.
PMID: 36241950 DOI: 10.1007/s11010-022-04549-3.
Hu J, Yan Q, Jiang H, Xu C, Chen Y, Yuan W Am J Transl Res. 2021; 13(11):12724-12733.
PMID: 34956487 PMC: 8661207.
Matta A, Karim M, Gerami H, Benigno B, Erwin W Sci Rep. 2021; 11(1):14804.
PMID: 34285277 PMC: 8292352. DOI: 10.1038/s41598-021-94173-w.